AstraZeneca's Tagrisso with addition of chemotherapy approved in Japan to treat patients with EGFR─mutated advanced lung ...
AstraZeneca’s Tagrisso (osimertinib) with the addition of pemetrexed and platinum-based chemotherapy has been approved in Japan for the 1st-line treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor-mutated (EGFRm …